Jazz Pharmaceuticals (JAZZ) total assets

Total assets · fiscal 2025
$11.66B

Jazz Pharmaceuticals (JAZZ) had total assets of $11.66B at the end of fiscal 2025 (December 31, 2025). That is 2.9% lower than the $12.01B of fiscal 2024. Figures as of 18 Nov 2026, 06:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$11.66B
Change on fiscal 2024
−2.9%
Growth, 5 years
+12.3% a year
Growth, 10 years
+13.3% a year
Highest on record
$12.30Bfiscal 2021
Lowest on record
$135.73Mfiscal 2010
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Jazz Pharmaceuticals total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 12.3% a year; over ten years the rate was 13.3% a year. Across the 16 fiscal years on record (2010–2025), the highest was $12.30B in fiscal 2021 and the lowest $135.73M in fiscal 2010.

History · 16 fiscal years

Total assets by fiscal year

Jazz Pharmaceuticals total assets, year by year

Jazz Pharmaceuticals (JAZZ) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$11.66B 2.9% down
2024$12.01B 5.4% up
2023$11.39B 5.2% up
2022$10.84B 11.9% down
2021$12.30B 88.2% up
2020$6.54B 18.0% up
2019$5.54B 6.4% up
2018$5.20B 1.6% up
2017$5.12B 6.7% up
2016$4.80B 44.0% up
2015$3.33B 0.2% down
2014$3.34B 49.2% up
2013$2.24B 13.8% up
2012$1.97B 675.5% up
2011$253.57M 86.8% up
2010$135.73M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Jazz Pharmaceuticals and comparable companies
CompanyTotal assetsFiscal year
Neurocrine Biosciences NBIX$4.63B2025
Ascendis Pharma ASND€1.30B2025
ICON ICLR$16.27B2025
Jazz Pharmaceuticals JAZZ$11.66B2025
Solventum SOLV$14.29B2025
BridgeBio Pharma BBIO$936.03M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on JAZZ

Jazz Pharmaceuticals, figure by figure

Jazz Pharmaceuticals (JAZZ) overview: price, valuation and scorecardAll health care companies by market value

Jazz Pharmaceuticals total assets: questions and answers

How large are Jazz Pharmaceuticals's total assets?

Jazz Pharmaceuticals (JAZZ) had total assets of $11.66B at the end of fiscal 2025 (December 31, 2025). That is 2.9% lower than the $12.01B of fiscal 2024.

What is the growth rate of Jazz Pharmaceuticals's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 12.3% a year; over ten years the rate was 13.3% a year.

What are the highest and lowest total assets figures on record for Jazz Pharmaceuticals?

Across the 16 fiscal years on record (2010–2025), the highest was $12.30B in fiscal 2021 and the lowest $135.73M in fiscal 2010.

How is Jazz Pharmaceuticals's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Jazz Pharmaceuticals (JAZZ) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/JAZZ/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.